Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia

Key facts

Sponsor

Johann Wolfgang Goethe University Hospital

Principal Investigator

Stefan Zielen, Prof. Dr.

Children's Hospital, Allergology, Pneumology and Cystic Fibrosis, Goethe-University

Intervention

bioelectrical impedance analysis(diagnostic_test)

Enrollment

30 enrolled

Eligibility

2-45 years · All sexes

Timeline

2016 – 2019

Study locations (1)

• Children's Hospital, Allergology, Pneumology and Cystic Fibrosis, Goethe University Frankfurt, Frankfurt am Main, Hesse, Germany

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Ataxia-telangiectasia

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGPHASE3NCT06673056
  A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)
  IntraBio Inc
• ACTIVE NOT RECRUITINGPHASE2NCT04870866
  NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia
  University Hospital, Akershus

See all trials for Ataxia-telangiectasia →